02 Jul 2024
// PRESS RELEASE
23 May 2024
// PRESS RELEASE
13 May 2024
// PRESS RELEASE
Latest Content by PharmaCompass
Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
About
CPhI North America CPhI North America
Industry Trade Show
Not Confirmed
20-22 May, 2025
Industry Trade Show
Attending
24-26 June, 2025
CBL & RAB BiocontrolCBL & RAB Biocontrol
Industry Trade Show
Attending
27-28 August, 2025
CONTACT DETAILS
Events
Webinars & Exhibitions
CPhI North America CPhI North America
Industry Trade Show
Not Confirmed
20-22 May, 2025
Industry Trade Show
Attending
24-26 June, 2025
CBL & RAB BiocontrolCBL & RAB Biocontrol
Industry Trade Show
Attending
27-28 August, 2025
CORPORATE CONTENT #SupplierSpotlight
02 Jul 2024
// PRESS RELEASE
https://www.bioiberica.com/en/media/news/bioiberica/bioiberica-obtains-self-determined-gras-status-collavant-n2-native-type-ii-collagen-unlocking-new-opportunities-us
23 May 2024
// PRESS RELEASE
https://www.bioiberica.com/en/media/news/heparina/ensuring-availability-medicines-all-key-we-are-part-critical-medicines-alliance
13 May 2024
// PRESS RELEASE
https://www.bioiberica.com/en/media/news/healthcare/our-hyaluronic-acid-matrix-ingredient-dermial-demonstrates-unique-skin-glow-effect-randomized-clinical-trial
23 Apr 2024
// PRESS RELEASE
https://www.bioiberica.com/en/media/news/bioiberica/bioiberica-we-engage-strategic-collaborations-lead-increased-innovation
08 Apr 2024
// PRESS RELEASE
https://www.bioiberica.com/en/media/news/healthcare/women-only-clinical-study-reveals-our-collavant-n2-native-undenatured-type-ii-collagen-shows-joint-health-benefits-40-mg
11 Mar 2024
// PRESS RELEASE
https://www.bioiberica.com/en/media/news/salud-vegetal/bioiberica-launches-new-probiotic-biostimulant-terra-sorb-symbiotic-optimization-fertilization
GDUFA
DMF Review : Complete
Rev. Date : 2013-05-09
Pay. Date : 2013-04-26
DMF Number : 17838
Submission : 2004-11-03
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31738
Submission : 2017-05-17
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26680
Submission : 2013-01-07
Status : Active
Type : II
Certificate Numbers : R1-CEP 2007-197 - Rev 02
Status : Valid
Issue Date : 2019-03-27
Type : TSE
Substance Number : 2064
Certificate Numbers : R1-CEP 2001-063 - Rev 06
Status : Valid
Issue Date : 2022-10-26
Type : TSE
Substance Number : 2064
Certificate Numbers : R1-CEP 2006-209 - Rev 04
Status : Valid
Issue Date : 2021-11-10
Type : Chemical and TSE
Substance Number : 2064
Certificate Numbers : CEP 2023-243 - Rev 02
Status : Valid
Issue Date : 2024-12-18
Type : Chemical and TSE
Substance Number : 2064
Certificate Numbers : CEP 2024-106 - Rev 00
Status : Valid
Issue Date : 2024-05-14
Type : Chemical
Substance Number : 2064
Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
Registration Number : 302MF10020
Registrant's Address : C/Antic Cami de Tordera, 109-119, Palafolls, 08389 Barcelona, Spain
Initial Date of Registration : 2020-01-31
Latest Date of Registration : 2021-10-21
Details:
Aim is to develop innovative multifunctional biomaterials to heal wounds using affordable EU-based manufacturing technologies.
Lead Product(s): Undisclosed
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Undisclosed
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 18, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioiberica Joins a European Project to Develop Treatments for Complex Wounds
Details : Aim is to develop innovative multifunctional biomaterials to heal wounds using affordable EU-based manufacturing technologies.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
January 18, 2023
Details:
By partnering with Bioiberica, ByHealth aims to capitalise on the untapped potential of new product development with native type II collagen and respond to the growing number of consumers looking to support their mobility with effective, convenient products across the country.
Lead Product(s): Undenatured Type II Collagen
Therapeutic Area: Musculoskeletal Brand Name: Collavant n2
Study Phase: Approved FDFProduct Type: Other Large Molecule
Sponsor: ByHealth
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership November 03, 2022
Lead Product(s) : Undenatured Type II Collagen
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : ByHealth
Deal Size : Undisclosed
Deal Type : Partnership
New Partnership With ByHealth in China
Details : By partnering with Bioiberica, ByHealth aims to capitalise on the untapped potential of new product development with native type II collagen and respond to the growing number of consumers looking to support their mobility with effective, convenient produ...
Product Name : Collavant n2
Product Type : Other Large Molecule
Upfront Cash : Undisclosed
November 03, 2022
Details:
New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.
Lead Product(s): Hyaluronic Acid,Collagen,Dermatan Sulfate
Therapeutic Area: Dermatology Brand Name: Dermial
Study Phase: PreclinicalProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 25, 2022
Lead Product(s) : Hyaluronic Acid,Collagen,Dermatan Sulfate
Therapeutic Area : Dermatology
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
New Study Reveals Bioiberica's Dermial® Delivers Superior Benefits for Skin Health
Details : New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.
Product Name : Dermial
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 25, 2022
Details:
Bioiberica’s native (undenatured) type II collagen, Collavant® n2 (previously b2-Cool®) and the addition of Tendaxion® - a new brand for its tendon health ingredient.
Lead Product(s): Chondroitin Sulfate Sodium
Therapeutic Area: Musculoskeletal Brand Name: CSbioactive
Study Phase: Approved FDFProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 07, 2021
Lead Product(s) : Chondroitin Sulfate Sodium
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioiberica Rebrands Its Range of Nutraceutical Ingredients for Healthcare
Details : Bioiberica’s native (undenatured) type II collagen, Collavant® n2 (previously b2-Cool®) and the addition of Tendaxion® - a new brand for its tendon health ingredient.
Product Name : CSbioactive
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 07, 2021
Details:
Apsen’s Motilex HA combines two leading ingredients, b-2Cool native type II collagen and Mobilee, patented ingredient that synergistically combines a high concentration of hyaluronic acid with polysaccharides and collagen, to effectively maintain joint function.
Lead Product(s): Hyaluronic Acid,Type II Collagen
Therapeutic Area: Musculoskeletal Brand Name: Motilex HA
Study Phase: Approved FDFProduct Type: Other Small Molecule
Sponsor: Apsen
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership April 26, 2021
Lead Product(s) : Hyaluronic Acid,Type II Collagen
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Apsen
Deal Size : Undisclosed
Deal Type : Partnership
Bioiberica and Apsen Reinforce Partnership with New Holistic Mobility Product–Motilex HA
Details : Apsen’s Motilex HA combines two leading ingredients, b-2Cool native type II collagen and Mobilee, patented ingredient that synergistically combines a high concentration of hyaluronic acid with polysaccharides and collagen, to effectively maintain joint...
Product Name : Motilex HA
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
April 26, 2021
Details:
B-2Cool (Bioiberica’s native type II collagen) is an innovative ingredient, has been shown in four scientific studies to help maintain good joint health at a very low daily dose.
Lead Product(s): Undenatured Type II Collagen,Harpagophytum Procumbens Extract,Hyaluronic Acid
Therapeutic Area: Musculoskeletal Brand Name: Collavant n2
Study Phase: Approved FDFProduct Type: Other Large Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 15, 2020
Lead Product(s) : Undenatured Type II Collagen,Harpagophytum Procumbens Extract,Hyaluronic Acid
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Laboratorios Ordesa Incorporates B-2cool®, Bioiberica’s Native Type II Collagen, in Its New Col...
Details : B-2Cool (Bioiberica’s native type II collagen) is an innovative ingredient, has been shown in four scientific studies to help maintain good joint health at a very low daily dose.
Product Name : Collavant n2
Product Type : Other Large Molecule
Upfront Cash : Inapplicable
July 15, 2020
Details:
The study, conducted in a rabbit model of osteoarthritis, set out to evaluate the effects of b-2Cool native type II collagen in combination with CS b-Bioactive chondroitin sulphate, glucosamine hydrochloride and Mobilee® which is a rooster comb extract rich in hyaluronic acid.
Lead Product(s): Undenatured Type II Collagen,Chondroitin Sulfate Sodium,Hyaluronic Acid
Therapeutic Area: Musculoskeletal Brand Name: Collavant n2
Study Phase: Approved FDFProduct Type: Other Large Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 09, 2020
Lead Product(s) : Undenatured Type II Collagen,Chondroitin Sulfate Sodium,Hyaluronic Acid
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
New Study Further Validates Bioiberica’s B-2cool® Native Type II Collagen as Trusted Source for...
Details : The study, conducted in a rabbit model of osteoarthritis, set out to evaluate the effects of b-2Cool native type II collagen in combination with CS b-Bioactive chondroitin sulphate, glucosamine hydrochloride and Mobilee® which is a rooster comb extract ...
Product Name : Collavant n2
Product Type : Other Large Molecule
Upfront Cash : Inapplicable
July 09, 2020
Excipients
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37583
Submission : 2022-10-28
Status : Active
Type : IV
Certificate Number : R1-CEP 2007-197 - Rev 02
Issue Date : 2019-03-27
Type :
Substance Number :
Status : Valid
Registrant Name : Donggu Biopharmaceutical Co., Ltd.
Registration Date : 2016-02-25
Registration Number : 20131119-173-I-277-03(7)
Manufacturer Name : Bioiberica, SAU
Manufacturer Address : C/ Antic Camí de Tordera, 109-119 08389 Palafolls (Barcelona), Spain
Inspections and registrations
ABOUT THIS PAGE
Bioiberica is a supplier offers 12 products (APIs, Excipients or Intermediates).
Find a price of Heparin Sodium bulk with DMF, JDMF offered by Bioiberica
Find a price of Chondroitin Sulfate Sodium bulk with CEP offered by Bioiberica
Find a price of Heparin Sodium bulk with DMF offered by Bioiberica
Find a price of Chondroitin Sulfate Sodium bulk offered by Bioiberica
Find a price of Glucosamine bulk offered by Bioiberica
Find a price of Glucosamine Hydrochloride bulk offered by Bioiberica
Find a price of Glucosamine Sulfate Potassium Chloride bulk offered by Bioiberica
Find a price of Glucosamine Sulfate Sodium Chloride bulk offered by Bioiberica
Find a price of Heparin Lithium bulk offered by Bioiberica
Find a price of Levothyroxine Sodium bulk offered by Bioiberica
Find a price of Liothyronine Sodium bulk offered by Bioiberica
Find a price of Thyroid bulk offered by Bioiberica